Conference Poster
Year :
Carole Brunaud : Connect in order to contact the contributor
https://hal-normandie-univ.archives-ouvertes.fr/hal-02386511
Submitted on : Friday, November 29, 2019-1:04:45 PM
Last modification on : Tuesday, March 29, 2022-6:26:02 PM
Dates and versions
Identifiers
- HAL Id : hal-02386511 , version 1
Cite
C Berthet, O Raguin, S Chalon, X Tizon, S Serrière, et al.. Preclinical proof of concept for the first [18F]-Nanocyclix®TKI-PET radiotracer targeting activated EGFR positive lung tumors. American Association for Cancer Research, Apr 2017, Washington, France. ⟨hal-02386511⟩
Collections
23
View
0
Download